Literature DB >> 27697753

Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective.

Neil Lineberry1, Jesse A Berlin2, Bernadette Mansi3, Susan Glasser4, Michael Berkwits5, Christian Klem6, Ananya Bhattacharya7, Leslie Citrome8, Robert Enck9, John Fletcher10, Daniel Haller11, Tai-Tsang Chen12, Christine Laine13.   

Abstract

Mesh：

Year:  2016        PMID： 27697753     DOI： 10.1136/bmj.i5078

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  26 in total

1.  Adverse Events Associated with Nonsurgical Treatments for Urinary Incontinence in Women: a Systematic Review.

Authors:  Ethan M Balk; Gaelen P Adam; Katherine Corsi; Amanda Mogul; Thomas A Trikalinos; Peter C Jeppson
Journal:  J Gen Intern Med       Date:  2019-05-06       Impact factor: 5.128

2.  Defining and measuring meditation-related adverse effects in mindfulness-based programs.

Authors:  Willoughby B Britton; Jared R Lindahl; David J Cooper; Nicholas K Canby; Roman Palitsky
Journal:  Clin Psychol Sci       Date:  2021-11-01

3.  Adverse Events of Physiotherapy Interventions in Parkinsonian Patients.

Authors:  Verónica Caniça; Raquel Bouça-Machado; Mário Miguel Rosa; Joaquim J Ferreira
Journal:  Mov Disord Clin Pract       Date:  2022-05-25

4.  Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.

Authors:  Hanna Bergman; Brian S Buckley; Gemma Villanueva; Jennifer Petkovic; Chantelle Garritty; Vittoria Lutje; Alina Ximena Riveros-Balta; Nicola Low; Nicholas Henschke
Journal:  Cochrane Database Syst Rev       Date:  2019-11-22

5.  Incidence and duration of common, early-onset adverse events occurring during 2 randomized, placebo-controlled, phase 3 studies of sodium oxybate in participants with narcolepsy.

Authors:  Aatif M Husain; Shay Bujanover; Robert Ryan; Brian Scheckner; Jed Black; Judi Profant
Journal:  J Clin Sleep Med       Date:  2020-09-15       Impact factor: 4.062

6.  Professional medical writing support and the reporting quality of randomized controlled trial abstracts among high-impact general medical journals.

Authors:  Ira Mills; Catherine Sheard; Meredith Hays; Kevin Douglas; Christopher C Winchester; William T Gattrell
Journal:  F1000Res       Date:  2017-08-16

7.  Do drugs offering only PFS maintain quality of life sufficiently from a patient's perspective? Results from AVALPROFS (Assessing the 'VALue' to patients of PROgression Free Survival) study.

Authors:  V Jenkins; V Farewell; S May; S Catt; L Matthews; V Shilling; J Dickson; R Simcock; L Fallowfield
Journal:  Support Care Cancer       Date:  2018-05-29       Impact factor: 3.603

8.  Harm, benefit and costs associated with low-dose glucocorticoids added to the treatment strategies for rheumatoid arthritis in elderly patients (GLORIA trial): study protocol for a randomised controlled trial.

Authors:  Linda Hartman; Linda A Rasch; Thomas Klausch; Hans W J Bijlsma; Robin Christensen; Yvo M Smulders; Stuart H Ralston; Frank Buttgereit; Maurizio Cutolo; Jose A P Da Silva; Daniela Opris; Jozef Rovenský; Szilvia Szamosi; Leonie M Middelink; Willem F Lems; Maarten Boers
Journal:  Trials       Date:  2018-01-25       Impact factor: 2.279

Review 9.  Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature.

Authors:  Philip J Budge; Carly Herbert; Britt J Andersen; Gary J Weil
Journal:  PLoS Negl Trop Dis       Date:  2018-05-16

10.  Methodological considerations in clinical outcomes assessment of pharmacy-based minor ailments management: A systematic review.

Authors:  Vibhu Paudyal; Scott Cunningham; Kathrine Gibson Smith; Katie MacLure; Cristin Ryan; Maria Cordina
Journal:  PLoS One       Date:  2018-10-04       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.